ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe. - Wikidata - wikimedia - TriplyDB

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

http://www.wikidata.org/entity/Q37600954

about

Comparing the effect of a leaflet and a movie in preventing tick bites and Lyme disease in The Netherlands.Arbovirosis and potential transmission blocking vaccines Evaluation and comparison of the potential of two ferritins as anti-tick vaccines against Haemaphysalis longicornis Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition Nuclease Tudor-SN Is Involved in Tick dsRNA-Mediated RNA Interference and Feeding but Not in Defense against Flaviviral or Anaplasma phagocytophilum Rickettsial Infection Vaccination against Lyme disease: Are we ready for it?Tick-borne encephalitis: What travelers should know when visiting an endemic country.Rickettsiaceae and Anaplasmataceae infections in Ixodes ricinus ticks from urban and natural forested areas of Poland.Prevention of tick bites: an evaluation of a smartphone app.The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern.Immunogenic potential of Rhipicephalus (Boophilus) microplus aquaporin 1 against Rhipicephalus sanguineus in domestic dogs.Control of Lyme borreliosis and other Ixodes ricinus-borne diseases.Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.Can interventions that aim to decrease Lyme disease hazard at non-domestic sites be effective without negatively affecting ecosystem health? A systematic review protocol A bite so sweet: the glycobiology interface of tick-host-pathogen interactions

P2860

Q27310153-97DBFE20-B41F-4F0B-9EBA-36DBA370060C Q27468657-10BCD0E0-92FD-419D-9EE0-B1EC754A3815 Q34340008-AFEDB5CD-0AD8-420F-B690-063DD2C8FA12 Q35547214-ACDDC9F2-D07A-4C7E-B32D-A58A0B5B9CD6 Q35695130-3AA6FE9C-5F89-42DF-B395-308143EC34E3 Q37135077-4C064EDE-92E8-4535-89D4-807FBA262A4A Q37375969-38EA0FEE-AEF3-45B1-9931-B29F8FA1C666 Q37714691-EF293445-B8E1-40A1-A2E6-6C24914160BB Q47105322-C703B438-A088-44E2-B72B-C43923FA5D62 Q47553266-8FEA3498-37B8-49E0-BE7F-39673F30E7C2 Q51127373-1D8C8B5A-2712-474C-B5E8-76763EBA9CCA Q52808425-C18B4F1E-F00A-42F6-BCF9-2711497143B8 Q54962520-76C28524-9B79-4190-9128-BE7E9A4755F0 Q57575070-C179C9F5-6135-446F-ACA8-5BD4D05D54D0 Q59135908-61F8DE6B-90DA-4C62-80C3-AE7AA4056FE6

P2860

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

http://www.wikidata.org/entity/Q37600954

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@en

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@nl

type

label

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@en

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@nl

prefLabel

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@en

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@nl

P1433

Q37600954-021B3DB9-2A3F-4193-B912-E12A77A47921

P1476

Q37600954-73DAA6C7-1735-4A12-872B-13A859B590E2

P2093

Q37600954-07B2004E-6C9D-489E-A0AD-6C8E978E517C

Q37600954-0A3425FC-E021-4783-A6F5-4C0D0D27CA3B

Q37600954-0E1F6838-6476-413A-B553-6ADC95201E71

Q37600954-57BFEF73-BA9C-42CD-942F-D67619FD9A88

Q37600954-58A7BCFE-03AA-4160-A584-F3D6FCFED88F

Q37600954-8239808F-9350-4427-80B8-B930931C2E6F

Q37600954-A40058B4-BC10-48EA-A8C5-EEB7C17DFED9

Q37600954-A6FAAF66-03F7-42EE-B5EB-C167B0F737B5

Q37600954-B9977D65-37B0-4453-B529-E23D47EE8D0D

Q37600954-E8A3A387-8517-4958-B4A7-4BD892666EE9

P2860

Q37600954-007A43FB-91F5-44F7-9E21-9E643300E9D5

Q37600954-084F0D88-E5AE-4DCC-9F9F-86EC4AA36A2B

Q37600954-0B92AC3D-8F77-4015-A285-87169A404546

Q37600954-0C665E2E-03D6-4B85-B7D1-5E481014EF7B

Q37600954-1988D9B2-C753-4A15-97E6-14932F96B9AF

Q37600954-219611B9-BD56-4179-8A81-54626A6DB43F

Q37600954-223E423B-321B-4AE8-9D27-E630B57AA647

Q37600954-244E8DC9-D23D-46BC-BFD9-24C64905B3DC

Q37600954-2A4C8672-B114-4FAB-9A3B-8E341090BB14

Q37600954-343BB9AE-E0E0-48C9-932C-25863FFFEBC2

P2888

Q37600954-976426C2-E39E-400E-8226-C874BA20A7AF

P304

Q37600954-D9E22D14-423E-4485-BCD5-F9771121BE3D

P31

Q37600954-1E3FCF1F-0423-4C63-8471-D2F025C2E414

P356

Q37600954-77454A65-9293-4BE0-BC14-F3C79A3431C2

P478

Q37600954-8883073F-2D53-41A5-98CB-E3CD10EEFBF1

P50

Q37600954-03BB12F8-CB03-4887-BE16-63796B258BFF

Q37600954-41D848EC-D99B-434D-8572-03996F180226

Q37600954-6CD0A2ED-F68E-4D08-9416-9B3508BAA065

Q37600954-A10135D0-2A5C-4495-8EB4-544A4370C2C4

Q37600954-BB038A06-E4FC-416C-AED2-A5B456B57D54

Q37600954-C48F923F-814E-45B4-872D-A3287A39E69B

P577

Q37600954-5C9569EF-05C4-4743-9370-538609FC62DD

P5875

Q37600954-7491E018-EDC4-4E50-85C0-9A6A5C71AFE6

P6179

Q37600954-C8E53CD0-EB5B-4FA8-81A3-5AEB049EB7EF

P698

Q37600954-E7C47A89-F39C-4B22-99D0-026989D52612

P932

Q37600954-91792B64-80F7-4CB7-90F1-62FC6E43DA3A

P356

P1433

Parasites & Vectors

P1476

ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.

@en

P2093

Bjorn Rotter

http://www.w3.org/2001/XMLSchema#string

Ingar Seemann

http://www.w3.org/2001/XMLSchema#string

Joppe W R Hovius

http://www.w3.org/2001/XMLSchema#string

Jos Trentelman

http://www.w3.org/2001/XMLSchema#string

Libor Grubhoffer

http://www.w3.org/2001/XMLSchema#string

Peter Winter

http://www.w3.org/2001/XMLSchema#string

Petr Kopáček

http://www.w3.org/2001/XMLSchema#string

Radek Šíma

http://www.w3.org/2001/XMLSchema#string

Sabina Havlíková

http://www.w3.org/2001/XMLSchema#string

Theo P Schetters

http://www.w3.org/2001/XMLSchema#string

P2860

Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden

Tick–host–pathogen interactions in Lyme borreliosis

An antivector vaccine protects against a lethal vector-borne pathogen.

The Lyme disease agent exploits a tick protein to infect the mammalian host

A clear and present danger: tick-borne diseases in Europe

Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe

Salivating for knowledge: potential pharmacological agents in tick saliva

Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent

Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display.

Lyme borreliosis in Europe.

P2888

P304

77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-3305-7-77

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Ondrej Hajdusek

P577

2014-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260372993

http://www.w3.org/2001/XMLSchema#string

P6179

1035609546

http://www.w3.org/2001/XMLSchema#string

P698

24559082

http://www.w3.org/2001/XMLSchema#string

P932

3933510

http://www.w3.org/2001/XMLSchema#string